Skip to content
Monday 24 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,854.32
+0.35%
DAX
26,106.60
-0.11%
CAC 40
8,453.01
-0.37%
STOXX 50
6,447.98
-0.22%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sunday 27 March 2022 7:49 am  |  Updated:  Sunday 27 March 2022 8:27 am

UK health authorities stunned as woman in London hospital has extremely rare Crimean-Congo haemorrhagic fever

By: Michiel Willems

Add as a preferred source on Google
Motorola's last chance to overturn competition watchdog charge control
Royal Free Hospital

The UK Health Security Agency (UKHSA) has confirmed to Morning Wire that an extremely rare case of Crimean-Congo haemorrhagic fever has been detected in England. The woman had recently travelled to Central Asia.

Crimean–Congo haemorrhagic fever is a viral disease usually transmitted by ticks and livestock animals in countries where the disease is endemic.

The patient was diagnosed at Cambridge University Hospitals NHS Foundation Trust and is receiving specialist care at the Royal Free Hospital in London.

“It’s important to be aware that Crimean-Congo haemorrhagic fever is usually spread by tick bites in countries where the disease is endemic, it does not spread easily between people and the overall risk to the public is very low,” said Susan Hopkins, Chief Medical Advisor at UKHSA.

“We are working with NHS EI to contact the individuals who have had close contact with the case prior to confirmation of their infection, to assess them as necessary and provide advice.

“UKHSA and the NHS have well established and robust infection control procedures for dealing with cases of imported infectious disease and these will be strictly followed,” Hopkins stressed.

Only third case ever

Prior to this case, there have been 2 cases of Crimean-Congo haemorrhagic fever imported to the UK, in 2012 and one in 2014. There was no evidence of onward transmission from either of these cases.

The principal carriers of Crimean-Congo haemorrhagic fever are Hyalomma ticks, these are not established in the UK and the virus has never been detected here in a tick.

People living in or visiting endemic areas should use personal protective measures to avoid contact with ticks, including avoiding areas where ticks are abundant at times when they are active, using tick repellents and checking clothing and skin carefully for ticks.

Read more

Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Transport & Infrastructure

Related Topics

  • NHS

Trending Articles

  • KPMG seeks financial support from parent group in wake of audit scandal

  • Greg Norman: I’d rather see LIV Golf end than wither away

  • Drive to Survive renewed by Netflix as Formula 1 docuseries gets ninth season

  • European private credit booms as private equity firms are forced to refinance

  • Burnham accused of ‘piecemeal’ business rates reform

More from Morning Wire

  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Domino’s battles for slice of fried chicken market as revenue jumps

    Retail
    Dominos chicken pesto pizza, sliced, with red onion, bell peppers, and melted cheese on a dark background.
  • Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook